Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinicopathologic and biological analysis of PIK3CA mutation in ovarian clear cell carcinoma.

Human pathology - 1 Dec 2012

Rahman Munmun, Nakayama Kentaro, Rahman Mohammed Tanjimur, Nakayama Naomi, Ishikawa Masako, Katagiri Atsuko, Iida Kouji, Nakayama Satoru, Otsuki Yoshiro, Shih Ie-Ming, Miyazaki Kohji

Abstract excerpt

Somatic mutations of PIK3CA (phosphoinositide-3-kinase) have recently been shown playing an important role in the pathogenesis of ovarian clear cell carcinoma. In this study, the frequency of PIK3CA mutations and the relationship of PIK3CA mutations with clinicopathologic and biological variables were investigated in ovarian clear cell carcinomas from Japanese patients. Mutational analysis of PIK3CA was performed...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma, Clear Cell
Share to Cell Line, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Class I Phosphatidylinositol 3-Kinases

Share to Ovarian Neoplasms

Share to Phosphatidylinositol 3-Kinases

Share to Phosphorylation

Share to Proto-Oncogene Proteins c-akt

Share to TOR Serine-Threonine Kinases

Source

Identifiers

PMID: 22705003
DOI: 10.1016/j.humpath.2012.03.011

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinicopathologic and biological analysis of PIK3CA mutation in ovarian clear cell carcinoma.PMID 22705003Read ↗

Frequent activating mutations of PIK3CA in ovarian clear cell carcinoma.Semantic proximity Read ↗

Clinical analysis and literature review of a case of ovarian clear cell carcinoma with PIK3CA gene mutation: A case report.Semantic proximity Read ↗

Molecular alterations of PIK3CA in uterine carcinosarcoma, clear cell, and serous tumors.Semantic proximity Read ↗

The PI3K/mTOR dual inhibitor NVP-BEZ235 reduces the growth of ovarian clear cell carcinomaSemantic proximity Read ↗

Prognostic significance of PI3K/AKT/ mTOR signaling pathway members in clear cell renal cell carcinomaSemantic proximity Read ↗

Establishment of a human ovarian clear cell carcinoma cell line mutant in PIK3CB but not PIK3CA.Semantic proximity Read ↗

Molecular status of PI3KCA, KRAS and BRAF in ovarian clear cell carcinoma: an analysis of 63 patients.Semantic proximity Read ↗

Antitumor Activity and Induction of TP53-Dependent Apoptosis toward Ovarian Clear Cell Adenocarcinoma by the Dual PI3K/mTOR Inhibitor DS-7423Semantic proximity Read ↗

PIK3CA mutations and loss of ARID1A protein expression are early events in the development of cystic ovarian clear cell adenocarcinoma.Semantic proximity Read ↗

A Link between mir-100 and FRAP1/mTOR in Clear Cell Ovarian CancerSemantic proximity Read ↗

Mutational status of KRAS, NRAS, and BRAF in primary clear cell ovarian carcinoma.Semantic proximity Read ↗

Sequence mutations and amplification of PIK3CA and AKT2 genes in purified ovarian serous neoplasms.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.